Publication: Variable immunogenicity of a vivax malaria blood-stage vaccine candidate
3
Issued Date
2021-05-06
Resource Type
ISSN
18732518
0264410X
0264410X
Other identifier(s)
2-s2.0-85103947427
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Vaccine. Vol.39, No.19 (2021), 2668-2675
Suggested Citation
Sai Lata De, Samuel May, Keshav Shah, Michelle Slawinski, Siriruk Changrob, Shulin Xu, Samantha J. Barnes, Patchanee Chootong, Francis B. Ntumngia, John H. Adams Variable immunogenicity of a vivax malaria blood-stage vaccine candidate. Vaccine. Vol.39, No.19 (2021), 2668-2675. doi:10.1016/j.vaccine.2021.03.072 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/76181
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Variable immunogenicity of a vivax malaria blood-stage vaccine candidate
Other Contributor(s)
Abstract
Relapsing malaria caused by Plasmodium vivax is a neglected tropical disease and an important cause of malaria worldwide. Vaccines to prevent clinical disease and mosquito transmission of vivax malaria are needed to overcome the distinct challenges of this important public health problem. In this vaccine immunogenicity study in mice, we examined key variables of responses to a P. vivax Duffy binding protein vaccine, a leading candidate to prevent the disease-causing blood-stages. Significant sex-dependent differences were observed in B cell (CD80+) and T cell (CD8+) central memory subsets, resulting in significant differences in functional immunogenicity and durability of anti-DBP protective efficacy. These significant sex-dependent differences in inbred mice were in the CD73+CD80+ memory B cell, H2KhiCD38hi/lo, and effector memory subsets. This study highlights sex and immune genes as critical variables that can impact host responses to P. vivax antigens and must be taken into consideration when designing clinical vaccine studies.